Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
45.85
-1.60 (-3.37%)
Aug 21, 2026, 4:00 PM EDT - Market closed

Supernus Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-109.89-38.5573.871.3260.7153.42
Depreciation & Amortization
101.791.5680.4184.8685.5432.6
Other Amortization
---0.532.1117.5
Asset Writedown & Restructuring Costs
54.92--20.19-15
Loss (Gain) From Sale of Investments
-0.55-1.091.81-0.123.220.07
Loss (Gain) on Equity Investments
-----12.89-
Stock-Based Compensation
34.633.0527.7626.7617.5717.91
Other Operating Activities
20.7237.52-9.85-13.31-15.2-12.94
Change in Accounts Receivable
-47.41-22.32.0818.77-16.373.87
Change in Inventory
-17.53-7.515.816.11-17.86-14.58
Change in Accounts Payable
-25.76-24.57-15.02-36.29-19.1618.18
Change in Other Net Operating Assets
9.11-20.79-4.922.2829.14-3.9
Operating Cash Flow
19.9147.33171.95111.09116.83127.13
Operating Cash Flow Growth
-89.36%-72.47%54.79%-4.91%-8.10%-8.14%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.12-1.34-0.73-0.55-0.41-2.05
Cash Acquisitions
-293.09-293.09----311.69
Investment in Securities
279.49298.54-189.14269.28-216.25231.82
Investing Cash Flow
-14.734.11-189.87268.73-216.66-81.91

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---93--
Long-Term Debt Issued
-----0.8
Total Debt Issued
---93-0.8
Short-Term Debt Repaid
----93--
Long-Term Debt Repaid
----402.5--138.32
Total Debt Repaid
----495.5--138.32
Net Debt Issued (Repaid)
----402.5--137.52
Issuance of Common Stock
50.0937.6214.916.6112.427.1
Repurchase of Common Stock
-5.49-4.23-2.72-1.99--
Other Financing Activities
-13.1-24.26---22.9-
Financing Cash Flow
31.519.1312.19-397.88-10.48-130.42

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
36.6960.57-5.72-18.07-110.31-85.21

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
18.7945.99171.23110.53116.41125.08
Free Cash Flow Growth
-89.89%-73.14%54.91%-5.05%-6.93%-7.15%
Free Cash Flow Margin
2.26%6.40%25.87%18.19%17.45%21.57%
Free Cash Flow Per Share
0.330.813.061.991.892.30
Levered Free Cash Flow
84.61101.29155.22161.7189.54116.37
Unlevered Free Cash Flow
86.06101.29155.22162.6991.84113.51

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
---1.952.522.52
Cash Income Tax Paid
3.8216.0553.2536.616.225.19
Change in Working Capital
-81.59-75.16-2.05-9.14-24.243.57
SEC Filings: 10-K · 10-Q